
Abstract Purpose Automated breast ultrasound (ABUS) is a standardized ultrasound technique that may reduce operator dependency compared with hand-held ultrasound. Evidence on patient acceptance and implementation in intensified breast cancer surveillance remains limited. This study evaluated patient acceptance and clinical implementation of ABUS within a certified center of the German Consortium for Hereditary Breast and Ovarian Cancer. Methods In this prospective single-center observational study, women enrolled in an intensified breast cancer surveillance program underwent ABUS examinations and completed standardized questionnaires. Patient-reported outcomes included examination-related discomfort, comparison with mammography, willingness to repeat the examination, and willingness to recommend ABUS. Workflow parameters and changes in acquisition time over repeated examinations were assessed prospectively. Results 73 women contributed 162 ABUS examinations and corresponding questionnaires. Of these, 46/73 (63.0%) carried pathogenic variants in BRCA1, BRCA2, PALB2, or TP53, and 27/73 (37.0%) had a previous breast cancer diagnosis. Median pain score was 0 (IQR 0–1) for both breasts. Among women with previous mammography and an available comparative rating, 56/57 (98.2%) rated ABUS as more comfortable. All 73 participants (100%) were willing to undergo future ABUS examinations and recommend the procedure. Mean acquisition and interpretation times were 31.9 ± 6.2 and 9.95 ± 4.0 min, respectively. Acquisition time decreased significantly with increasing examination number ( β = − 1.72 min/examination; p < 0.001). Conclusions ABUS was associated with high reported patient acceptance and was feasible to integrate into intensified breast cancer surveillance, with improving acquisition efficiency over time.
Histone modifications play a key role in chromatin organization and transcriptional regulatory potential. Previously, reduced levels of trimethylated histone H3K4me3 and acetylated H3K9ac were observed in placentas from women with preeclampsia. Building on these findings, this study investigated whether SARS-CoV-2 infection during pregnancy or at delivery is associated with changes in placental histone modifications. Immunohistochemical staining, exploratory western blot analysis, and qualitative immunofluorescence were performed on placental sections from 60 patients stratified into four groups: women with acute SARS-CoV-2 infection at delivery, women with prior infection during gestation, vaccinated controls, and unvaccinated controls. H3K4me3 levels in the syncytiotrophoblast were significantly reduced in both SARS-CoV-2-exposed groups compared to unvaccinated controls, with the most pronounced reduction observed in women with prior infection during gestation. H3K9ac levels did not differ significantly between groups in any compartment after correction for multiple comparisons. No significant associations were found between SCT H3K4me3 levels and maternal age, gestational age, or birthweight, and a sensitivity analysis excluding cases with additional placental pathologies confirmed the robustness of the findings. As no gene expression profiling was performed, functional or transcriptional consequences of the observed H3K4me3 changes cannot be inferred. These descriptive findings warrant further investigation integrating epigenetic and transcriptomic approaches to clarify their functional relevance for placental biology and pregnancy outcomes.
Abstract Purpose Elective (pre-labour) cesarean sections are, by design, concentrated during staffed hours, limiting the interpretability of overall temporal patterns. We examined whether the proportion of documented discretion-susceptible indications for non-elective (intrapartum) cesarean sections shifts with time of day and weekday, using the Robson classification for stratification. Methods We retrospectively analysed 5,850 cesarean sections at University Hospital Giessen and Marburg, 2015–2021, classified as elective ( n =2,851) or non-elective ( n =2,998) by documented decision timepoint. Among non-elective cases, we assessed threshold-susceptible ("soft") indications (protracted labour/arrest, non-reassuring fetal heart rate) by shift and weekend, adjusted for Robson group and gestational age. Guideline-defined absolute ("hard") indications served as a supportive comparison, with Holm correction for exploratory comparisons. Results Among non-elective cesarean sections, the proportion with documented discretion-susceptible indications was significantly higher during evening/night shifts (OR 2.63, 95%CI 2.20–3.14, p <0.001) and, less markedly, on weekends (OR 1.37, 95%CI 1.12–1.67, p =0.002), consistent across all five individual indicators for shift, and across two of five for weekend. Indications with limited clinical discretion showed no comparable variation (shift OR 0.99, p =0.92; weekend OR 0.77, p =0.16), except for placenta previa (Holm- p =0.023), discussed as a qualification rather than a validation of the primary interpretation. Conclusion The proportion of non-elective cesarean sections with documented discretion-susceptible indications was higher during evening/night shifts and weekends, while guideline-defined indications with limited discretion showed comparatively little variation. Because a population-based at-risk denominator was unavailable, these findings describe differences in documented indication composition among cesarean deliveries that occurred, rather than evidence that the intervention threshold itself changed. Whether this reflects clinical decision-making, documentation practice, or unmeasured case-mix factors warrants further investigation.
The assessment of fetal well-being remains challenging. Despite the development of several surveillance methods, preventing metabolic acidosis and adverse neonatal outcomes without increasing unnecessary obstetric intervention remains difficult. Lactate levels have been evaluated in maternal blood, umbilical cord blood, fetal scalp blood, and, with growing interest, amniotic fluid. Although lactate exchange between the maternal, uteroplacental, and fetal compartments is not fully understood, amniotic fluid lactate (AFL) has been investigated as a potential marker of uterine metabolic activity and labor progression. Higher AFL concentrations have been associated with labor dystocia and operative delivery in some studies. Accordingly, AFL assessment may provide complementary information on labor progression, but its potential role as an adjunct to fetal surveillance and routine clinical decision-making requires further investigation and validation. Interventions aimed at reducing elevated AFL concentrations during labor have also been proposed. However, evidence that AFL-guided treatment improves obstetric or neonatal outcomes remains limited. Further technological development and prospective clinical validation may clarify whether AFL assessment could support existing maternal and fetal surveillance strategies. This narrative review examines lactate physiology during pregnancy and labor and evaluates the potential role of lactate measurements as adjunctive biomarkers and as possible guides for future therapeutic strategies.
Since July 2022, non-invasive prenatal testing (NIPT) for trisomies 21, 18, and 13 has been available as a statutory health insurance (GKV) benefit in Germany. It is not a routine examination offered to all pregnant women; according to the Maternity Directives of the Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA), it is reimbursed in justified individual situations after physician-led counselling. While uptake data have been reported from the healthcare provider perspective, patients’ knowledge, counselling experiences, motivations, and intended post-test decisions have not been systematically studied in a multicenter German cohort since NIPT became a GKV benefit. A multicenter, exploratory, anonymous questionnaire-based survey was conducted at seven prenatal diagnostic centres across Germany between June and November 2024. Pregnant women who had already undergone GKV-NIPT were invited to participate. The questionnaire addressed four domains: (1) counselling and informed consent, (2) factual knowledge about GKV-NIPT, (3) motivation for testing, and (4) reactions and intended post-test decisions. A composite knowledge score was calculated from six factual items (Q4, Q5, Q7–Q10); the intended use of confirmatory amniocentesis (Q17) was analysed exclusively as an outcome variable. Descriptive statistics and Spearman rank correlations were applied. Ethics approval was obtained from the University of Heidelberg Ethics Committee (S-259/2024). A total of 1252 questionnaires were distributed across the seven centres, of which 645 were returned (overall response rate 51.5